NMTC — NEUROONE MEDICAL TECHNOLOGIES Corp
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1500198 ·
Last close
$3.32
Market Cap
$28.89M
52W High
$5.40
52W Low
$3.11
ADV30
33,392
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 2,391,185 | 1,286,617 | -2,100,844 | -2,085,669 | 7,864,958 | 2,804,011 | 2,491,322 |
| Dec 2025 | 2,892,635 | 1,567,828 | -1,707,307 | -1,437,890 | 8,577,602 | 3,561,616 | 2,175,677 |
| Sep 2025 | 2,740,925 | 1,528,621 | -1,371,064 | -1,619,221 | 10,785,647 | 6,570,382 | 3,713,125 |
| Jun 2025 | 1,696,050 | 914,835 | -1,886,600 | -1,500,868 | 10,819,481 | 8,039,683 | 2,642,028 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-7,433,723
Investing CF
$-133,425
Financing CF
$9,050,908
CapEx
$-133,425
Dividends Paid
—
Buybacks
$-70,654
EPS Diluted TTM
$-1.03
As of
2026-06-07
Balance + Analyst (yfinance extras)
Retained Earnings
$-82,133,346
Inventory
$1,866,633
Receivables
$2,426,518
ST Investments
—
EBIT TTM
$-6,634,323
Pretax Income TTM
$-6,643,648
Interest Exp TTM
$9,325
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$12,720,795
EBITDA
$-6,809,345
Free Cash Flow
$-5,359,147
Enterprise Value
$26,020,950
Total Cash
$2,804,011
Total Debt
$206,973
Shares Out
8,702,982
Trailing EPS
$-0.89
Book Value
$0.62
ROE
-204.4%
ROA
-71.7%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Sep 2025 | 9,097,692 | -4,226,473 | -3,605,374 | 10,785,647 | 3,713,125 | — | -2,837,272 |
| Sep 2024 | 3,453,003 | -11,887,209 | -12,318,110 | 5,369,940 | 4,547,927 | — | -11,011,840 |
| Sep 2023 | 1,952,441 | -11,955,250 | -11,859,491 | 8,097,314 | 1,847,910 | — | -12,886,874 |
| Sep 2022 | 171,169 | -10,030,765 | -9,999,613 | 12,822,609 | 3,218,245 | — | -7,519,534 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.28
Max Pain — expiry 2026-10-16 (volume-derived — Yahoo OI feed degraded)
max pain strike: $5.00 · spot: $3.35 · call volume: 10 · put volume: 10
Expected Move to 2026-10-16:
±$2.90
(86.57%) —
implied range
$0.45 –
$6.25
· ATM straddle on $2.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| PETV | PetVivo Holdings, Inc. | $29.32M | $0.80 | — |
| MODD | Modular Medical, Inc. | $28.46M | $5.26 | — |
| MLSS | MILESTONE SCIENTIFIC INC. | $29.77M | $0.34 | — |
| CTSO | Cytosorbents Corp | $27.13M | $0.43 | — |
| RDGL | VIVOS INC | $32.10M | $0.06 | — |
News headlines (Yahoo Finance, 1h cache)
NeuroOne(R) Announces Preliminary Inclusion in Russell Microcap(R) Index
2026-06-16 12:30 · Yahoo
NeuroOne(R) to Present at the Planet MicroCap Las Vegas 2026 Conference Wednesday, June 17, 2026 at 12:00 p.m. Pacific Time
2026-06-08 12:30 · Yahoo
NeuroOne(R) to Present at the 2026 American Society for Stereotactic and Functional Neurosurgery Biennial Meeting on May 31, 2026
2026-05-28 12:30 · Yahoo
NeuroOne(R) Medical Technologies Announces Restatement of Financial Results for Quarter Ending March 31, 2026
2026-05-22 20:30 · Yahoo
NeuroOne Medical Technologies Corp (NMTC) Q2 2026 Earnings Call Highlights: Strong Product ...
2026-05-12 23:02 · Yahoo
NeuroOne Reports Fiscal Q2 2026 Financial Results and Provides Corporate Business Update
2026-05-12 12:00 · Yahoo
NeuroOne(R) Regains Compliance With Nasdaq Listing Requirement
2026-05-04 12:30 · Yahoo
NeuroOne(R) Announces Chief Financial Officer Succession Plan
2026-04-30 12:30 · Yahoo
NeuroOne(R) to Report Second Quarter Fiscal Year 2026 Financial Results on Tuesday, May 12 at 8:30 a.m. Eastern Time
2026-04-28 12:30 · Yahoo
NeuroOne(R) Advances Brain Drug Delivery Platform Through Collaboration With University of Minnesota
2026-04-15 12:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.